London, UK, 6 July 2011
Chiltern Announces New Legal Entity in Israel
Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO), announced that the company has established a new legal entity in Israel.

Chiltern has experienced a healthy number of requests from our clients in this region and forming a legal entity is a natural progression to our work there,” commented Armand Czaplinski, Chiltern’s Executive Director, Global Country Management, who will be leading the effort in Israel. “Israel is an attractive location to conduct clinical trials as it has many key opinion leaders (KOL) in clinical research and outstanding quality of research. Israel has some of the most skilled and educated work forces with the highest number of doctors, scientists and engineers per capita than any other country. Another key advantage is that the majority of Israel’s population belongs to the same health maintenance organization and this facilitates quick start for clinical trials and reduces the overall project timelines.

Download the Press Release

Back to headlines

In The Media
Chiltern Wins CRO Leadership Award from Life Science Leader, 6 March 2014 More
Chiltern Partners with Karolinska Development, 12 February 2014 More
Chiltern Wins PharmaTimes Awards, 31 January 2014 More
Chiltern Announces the Consolidation of Existing Investor Base, 17 December 2013 More
Chiltern Appoints Andrew Monaghan Director Global Pharmacovigilance, 24 July 2013 More